Profit Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Profit Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,137	Closed	-$382K	–	80
2021 Q4	$382K	Hold	6,137	–	–	0.24%	74
2021 Q3	$363K	Hold	6,137	–	–	0.25%	71
2021 Q2	$410K	Hold	6,137	–	–	0.22%	73
2021 Q1	$387K	Hold	6,137	–	–	0.22%	74
2020 Q4	$380K	Hold	6,137	–	–	0.24%	72
2020 Q3	$370K	Hold	6,137	–	–	0.23%	78
2020 Q2	$361K	Sell	6,137 -3,933	-39%	-$235K	0.25%	76
2020 Q1	$561K	Hold	10,070	–	–	0.53%	62
2019 Q4	$646K	Buy	+10,070	New	+$577K	0.43%	65

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Profit Investment Management's BMY Position: Q1 2022 in Review

Profit Investment Management sold out of Bristol-Myers Squibb (BMY) in Q1 2022, closing a stake of 6,137 shares — an estimated $382K sold.

Profit Investment Management first reported a position in BMY in Q4 2019 and held it in 9 quarters. The position peaked at $646K in Q4 2019. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

Profit Investment Management reported no remaining Bristol-Myers Squibb position as of Q1 2022 after selling out during the quarter.
Profit Investment Management sold 6,137 Bristol-Myers Squibb shares in Q1 2022, an estimated $382K.
Profit Investment Management first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 9 quarters.
Profit Investment Management's Bristol-Myers Squibb position peaked at $646K in Q4 2019.
2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on Profit Investment Management's 13F filing for Q1 2022, filed 20 Apr 2022.